EpiVax, Inc. and Zoetis Inc. announce an exclusive collaboration to develop CircoMatchÖ, a unique bioinformatics tool that predicts the coverage of Porcine Circovirus Type 2 (PCV2) vaccines against field isolates of PCV2. The new tool provides a quick turnaround, powerful way to provide near real-time predictive effectiveness data so swine veterinarians and producers can make informed decisions in vaccination programs. CircoMatchÖ applies the EpiVax EpiCC (Epitope Content Comparison) tool and EpiVaxPigMatrix algorithm in a custom-built website, which performs a detailed comparison between PCV2 vaccines and circulating field strains of the PCV2 virus. These proprietary computational tools allow for a practical prediction of effectiveness for existing commercial vaccines and may aid in the development of vaccines that are more efficacious across different viral variants.

Zoetis and EpiVax will be sharing more details on this new collaboration during the upcoming Conference of Research Workers in Animal Diseases (CRWAD) meeting in Chicago, January 22-24, 2023.